Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 2
2016 1
2017 4
2019 2
2020 6
2021 6
2022 7
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
The Use of an Adjuvant System Improves Innate and Adaptive Immune Response When Associated with a Leishmania (Viannia) braziliensis Antigen in a Vaccine Candidate against L. (Leishmania) infantum Infection.
Mathias FAS, Ostolin TLVDP, Reis LES, Cardoso JMO, De Brito RCF, Aguiar Soares RDO, Roatt BM, Vieira PMA, Reis AB. Mathias FAS, et al. Among authors: cardoso jmo. Vaccines (Basel). 2023 Feb 9;11(2):395. doi: 10.3390/vaccines11020395. Vaccines (Basel). 2023. PMID: 36851272 Free PMC article.
LBMPL Vaccine Therapy Induces Progressive Organization of the Spleen Microarchitecture, Improved Th1 Adaptative Immune Response and Control of Parasitism in Leishmania infantum Naturally Infected Dogs.
Roatt BM, de Oliveira Cardoso JM, Reis LES, Moreira GJL, Gonçalves LC, de Souza Marques F, das Dores Moreira N, de Abreu Vieira PM, de Oliveira Aguiar-Soares RD, Giunchetti RC, Reis AB. Roatt BM, et al. Among authors: de oliveira cardoso jm. Pathogens. 2022 Aug 26;11(9):974. doi: 10.3390/pathogens11090974. Pathogens. 2022. PMID: 36145406 Free PMC article.
CD4+ T-lymphocytes from asymptomatic dogs infected with Leishmania infantum are able to activate macrophages for higher leishmanicidal ability in an in vitro co-culture experiment.
Vieira JFP, de Oliveira Cardoso JM, de Brito RCF, Roatt BM, Carneiro CM, Valadares DG, de Oliveira Aguiar-Soares RD, Reis AB. Vieira JFP, et al. Among authors: de oliveira cardoso jm. Mol Immunol. 2022 Nov;151:61-69. doi: 10.1016/j.molimm.2022.08.013. Epub 2022 Sep 7. Mol Immunol. 2022. PMID: 36087461
A specific Leishmania infantum polyepitope vaccine triggers Th1-type immune response and protects against experimental visceral leishmaniasis.
Lopes Valentim Di Paschoale Ostolin T, Rodrigues Gusmão M, Augusto Siqueira Mathias F, Mirelle de Oliveira Cardoso J, Mendes Roatt B, Dian de Oliveira Aguiar-Soares R, Conceição Ruiz J, de Melo Resende D, Cristiane Fortes de Brito R, Barbosa Reis A. Lopes Valentim Di Paschoale Ostolin T, et al. Among authors: mirelle de oliveira cardoso j. Cell Immunol. 2022 Oct;380:104592. doi: 10.1016/j.cellimm.2022.104592. Epub 2022 Sep 5. Cell Immunol. 2022. PMID: 36084402
Immunoprophylaxis using polypeptide chimera vaccines plus adjuvant system promote Th1 response controlling the spleen parasitism in hamster model of visceral leishmaniasis.
Gusmão MR, Ostolin TLVDP, Carvalho LM, Costa AFP, Moreira GJL, Cardoso JMO, Aguiar-Soares RDO, Reis AB, de Brito RCF, Roatt BM. Gusmão MR, et al. Among authors: cardoso jmo. Vaccine. 2022 Sep 2;40(37):5494-5503. doi: 10.1016/j.vaccine.2022.08.005. Epub 2022 Aug 10. Vaccine. 2022. PMID: 35963820 Free article.
Heterologous vaccine therapy associated with half course of Miltefosine promote activation of the proinflammatory response with control of splenic parasitism in a hamster model of visceral leishmaniasis.
Carvalho LM, Ferreira FC, Gusmão MR, Costa AFP, de Brito RCF, Aguiar-Soares RDO, Reis AB, Cardoso JMO, Carneiro CM, Roatt BM. Carvalho LM, et al. Among authors: cardoso jmo. Curr Res Immunol. 2021 Nov 5;2:194-201. doi: 10.1016/j.crimmu.2021.10.003. eCollection 2021. Curr Res Immunol. 2021. PMID: 35492387 Free PMC article.
Immunochemotherapy for visceral leishmaniasis: combinatorial action of Miltefosine plus LBSapMPL vaccine improves adaptative Th1 immune response with control of splenic parasitism in experimental hamster model.
Carvalho LM, Gusmão MR, Costa AFP, de Brito RCF, Aguiar-Soares RDO, Cardoso JMO, Reis AB, Carneiro CM, Roatt BM. Carvalho LM, et al. Among authors: cardoso jmo. Parasitology. 2022 Mar;149(3):371-379. doi: 10.1017/S0031182021001906. Epub 2021 Nov 2. Parasitology. 2022. PMID: 35264268 Free PMC article.
Down regulation of IL-10 and TGF-β1 mRNA expression associated with reduced inflammatory process correlates with control of parasitism in the liver after treatingL. infantuminfected dogs with the LBMPL vaccine therapy.
Mendes Roatt B, Mirelle de Oliveira Cardoso J, Cristiane Fortes de Brito R, Eduardo Soares Reis L, José Lucas Moreira G, Melo de Abreu Vieira P, Marques de Souza F, Geraldo de Lima W, Dian de Oliveira Aguiar-Soares R, Cordeiro Giunchetti R, Barbosa Reis A. Mendes Roatt B, et al. Among authors: mirelle de oliveira cardoso j. Cytokine. 2022 May;153:155838. doi: 10.1016/j.cyto.2022.155838. Epub 2022 Mar 5. Cytokine. 2022. PMID: 35259630 Free article.
Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis.
Cardoso JMO, Brito RCF, Mathias FAS, Reis LES, Vieira JFP, Ostolin TLVDP, Andrade HM, Ramos GS, Frézard F, Aguiar-Soares RDO, Roatt BM, Reis AB. Cardoso JMO, et al. Mol Immunol. 2022 Jan;141:70-78. doi: 10.1016/j.molimm.2021.11.011. Epub 2021 Nov 20. Mol Immunol. 2022. PMID: 34814056
30 results